Alkem Laboratories Limited

NSE:ALKEM.NS

5706.5 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 30,318.229,358.233,238.734,401.729,677.229,02630,409.130,793.725,763.823,61726,189.827,999.927,313.620,555.523,180.523,62820,034.918,965.921,818.422,640.318,49517,628.619,250.319,189.216,694.615,132.317,404.718,649.412,952.412,51414,622.316,150.114,393.611,485.512,459.913,618.811,960.39,550.39,685.59,415.69,415.6
Cost of Revenue 17,58716,966.613,046.413,270.711,985.712,555.212,489.413,069.510,954.311,343.59,966.810,574.710,947.910,308.58,876.89,339.47,338.610,028.18,344.39,0437,118.28,254.58,2307,639.76,660.86,160.36,263.97,080.95,623.94,607.95,404.96,413.75,788.84,3065,089.25,493.54,744.94,626.24,117.94,831.34,831.3
Gross Profit 12,731.212,391.620,192.321,13117,691.516,470.817,919.717,724.214,809.512,273.516,22317,425.216,365.710,24714,303.714,288.612,696.38,937.813,474.113,597.311,376.89,374.111,020.311,549.510,033.88,97211,140.811,568.57,328.57,906.19,217.49,736.48,604.87,179.57,370.78,125.37,215.44,924.15,567.64,584.34,584.3
Gross Profit Ratio 0.420.4220.6070.6140.5960.5670.5890.5760.5750.520.6190.6220.5990.4990.6170.6050.6340.4710.6180.6010.6150.5320.5720.6020.6010.5930.640.620.5660.6320.630.6030.5980.6250.5920.5970.6030.5160.5750.4870.487
Reseach & Development Expenses 1,2571,7571,1111,1581,2021,4721,2971,3051,3205,690.41,4491,4071,1831,4081,3351,3931,1861,266.51,2051,2341,0341,405.11,19509863,658.8007013,216.8065002,178.3040301,695.50347.05347.05
General & Administrative Expenses 0-615.9000-1,749.30004,828.6000625.90003,439.30003,885.90003,309.10002,152.20001,749.50001,852.30190.75190.75
Selling & Marketing Expenses 08,0650008,185.80005,968.20003,456.50005,657.60004,705.70004,316.30003,613.90002,844.20002,395.401,048.851,048.85
SG&A 6,192.67,449.16,284.96,951.95,676.56,436.55,378.56,171.65,321.510,796.84,7094,944.93,935.84,082.44,097.54,080.13,942.39,096.93,956.23,896.33,903.28,591.63,463.53,278.63,394.57,625.43,113.73,0782,737.95,766.12,842.92,760.12,540.64,593.72,336.92,398.42,282.24,247.71,354.83,287.63,287.6
Other Expenses 1,203.1881.7936.4631.9658.4686.7453.3506.7514.1-1,170.1535.2419.6466.5-1,805.5964355.4435-735.6278.6314.2174.7-505.493.5240.2162.5178.7245.8240.1294.9246.1254339.3280.71,035.8330.4704.3475.4-1,248.2389.800
Operating Expenses 7,449.69,206.113,81314,402.714,523.713,721.512,713.613,959.113,539.79,690.612,013.111,909.711,142.47,9859,702.68,986.18,032.86,194.19,536.29,635.49,290.17,330.88,379.48,365.58,3168,237.87,917.77,309.66,691.16,677.26,799.96,886.56,123.35,862.35,261.35,830.15,359.43,5224,069.13,730.93,730.9
Operating Income 5,281.63,185.57,316.77,360.23,167.83,4365,659.44,271.81,269.82,483.44,209.95,515.55,223.32,2624,601.15,302.54,663.52,743.73,937.93,961.92,086.72,043.32,640.93,1841,717.8734.23,223.14,258.9637.41,228.92,417.52,849.92,481.51,317.22,109.42,295.21,8561,402.11,498.5872.75872.75
Operating Income Ratio 0.1740.1090.220.2140.1070.1180.1860.1390.0490.1050.1610.1970.1910.110.1980.2240.2330.1450.180.1750.1130.1160.1370.1660.1030.0490.1850.2280.0490.0980.1650.1760.1720.1150.1690.1690.1550.1470.1550.0930.093
Total Other Income Expenses Net 912487.9-767.7-879.8360.7-1,319.4-270.5-248.5249.1-56.6429.5299.9337.9319.6833.3175264-390.7108.2136.713.5-55.2-60.376.2-0.174.310161.6169.3131.6136.8219181.1935.2160.5501.7250.8101.8180.7131.35131.35
Income Before Tax 6,193.63,673.46,5496,480.43,528.52,116.65,388.94,023.31,518.92,426.84,639.45,815.45,561.22,581.65,434.45,477.54,927.52,3534,046.14,098.62,100.21,988.12,580.63,260.21,717.7808.53,324.14,320.5806.71,360.52,554.33,068.92,662.62,252.42,269.92,796.92,106.81,503.91,679.21,004.11,004.1
Income Before Tax Ratio 0.2040.1250.1970.1880.1190.0730.1770.1310.0590.1030.1770.2080.2040.1260.2340.2320.2460.1240.1850.1810.1140.1130.1340.170.1030.0530.1910.2320.0620.1090.1750.190.1850.1960.1820.2050.1760.1570.1730.1070.107
Income Tax Expense 691.2628.6506.2331.5650.41,439.8789.3546.1204.41,344.7-694.1230.1758.989.4795.9662.4695.6437.6146.5293.4227.3283.1526.1656345145.21,515.41,046.1168.9-9.1191.7187.4229.61,387345.481.268.1188.864.4148.25148.25
Net Income 5,451.62,935.65,949.66,205.22,867.3709.84,547.13,308.41,276.41,075.85,256.65,442.64,681.22,399.94,509.64,720.64,220.11,887.73,819.83,708.51,854.71,673.62,025.32,544.71,361.5670.81,716.43,206.6715.61,370.12,3342,828.32,387.9866.81,889.32,669.22,0111,315.11,614.8855.85855.85
Net Income Ratio 0.180.10.1790.180.0970.0240.150.1070.050.0460.2010.1940.1710.1170.1950.20.2110.10.1750.1640.10.0950.1050.1330.0820.0440.0990.1720.0550.1090.160.1750.1660.0750.1520.1960.1680.1380.1670.0910.091
EPS 45.624.5549.7651.923.985.9438.0327.6710.68943.9645.5239.1520.0737.7239.4835.315.7931.9531.0215.511416.9421.2811.395.6114.3626.825.9911.4619.5223.6519.977.2515.6322.3216.821113.57.167.16
EPS Diluted 45.624.5549.7651.923.985.9438.0327.6710.68943.9645.5239.1520.0737.7239.4835.315.7931.9531.0215.511416.9421.2811.395.6114.3626.825.9911.4619.5223.6519.977.2515.6322.3216.821113.57.167.16
EBITDA 6,086.44,019.88,012.38,099.24,550.34,219.26,443.85,045.82,546.53,339.25,519.76,663.46,395.12,400.76,255.16,360.35,766.83,388.44,811.34,840.12,819.72,605.93,211.33,881.92,304.81,316.23,843.94,844.71,238.61,738.72,935.23,4442,991.72,594.52,684.23,258.72,537.51,8162,100.71,027.61,027.6
EBITDA Ratio 0.2010.1370.2410.2350.1530.1450.2120.1640.0990.1410.2110.2380.2340.1170.270.2690.2880.1790.2210.2140.1520.1480.1670.2020.1380.0870.2210.260.0960.1390.2010.2130.2080.2260.2150.2390.2120.190.2170.1090.109